Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study
Reason given: No funding
Key facts
- Where
- Bordeaux, Limoges, Nice, Paris, Poitiers, Saint-Denis, Thionville, and Tours, FranceSee the 9 sites
Where in France
- CHU de BordeauxBordeaux, FranceNo longer taking part
- CHU de LimogesLimoges, FranceNo longer taking part
- CHU de NiceNice, FranceNo longer taking part
- Hôpital Lariboisière APHPParis, FranceNo longer taking part
- Hôpital Saint-AntoineParis, FranceNo longer taking part
- CHU de PoitiersPoitiers, FranceNo longer taking part
- CHU de la RéunionSaint-Denis, FranceNo longer taking part
- Centre de Cardiologie de ThionvilleThionville, FranceNo longer taking part
- CHU de ToursTours, FranceNo longer taking part
Trial details
- Who runs it
- French Cardiology Society
- Trial code
- NCT05314140
- Record updated
- 17 February 2026
- Original description
There are currently only few data on the coronary artery calcium score in patient with diabetes in France, and the diagnostic and therapeutic attitudes towards a high coronary artery calcium score are not standardized and depend on clinical practices, which may vary from one center to another. The proposed multicenter prospective study would provide a better understanding of the epidemiological particularities of the coronary artery calcium score in French diabetics, refine the indications for better performance of the examination, and compare attitudes when this score is high.Read full original descriptionShow less
There are currently only few data on the coronary artery calcium score in patient with diabetes in France, and the diagnostic and therapeutic attitudes towards a high coronary artery calcium score are not standardized and depend on clinical practices, which may vary from one center to another. The proposed multicenter prospective study would provide a better understanding of the epidemiological particularities of the coronary artery calcium score in French diabetics, refine the indications for better performance of the examination, and compare attitudes when this score is high.
Inclusion: Coronary asymptomatic patient; Patient with type 2 diabetes and aged 50 to 70 or - Patient with type 2 diabetes for more than 10 years and aged 18 to 50 or - Patient with type 1 diabetes for more than 20 years and aged > 35; Coronary artery calcium score evaluation planned.
Exclusion: Patients who already have a clinical history of coronary disease; Patients with other peripheral arterial disease; Patients with clinical suspicion of coronary artery disease; Patients with progressive cancer; Patients with serious chronic conditions with an estimated life expectancy < 3 years; Pregnant, lactating, or pre-menopausal women without a recent negative pregnancy test available; Patients under guardianship or curator or placed under justice safeguard; Patients who do not benefit from the social security scheme, or any equivalent scheme; Patients refusing or being linguistically or psychologically unable to sign the informed consent form; Participation in another biomedical research protocol is permitted.